Xunlei Ltd: Form 20-F for the period ended Dec 31, 2024
Filed with the SEC on Apr 24, 2025 and accepted by EDGAR at Apr 24, 2025, 16:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $323.1m | us-gaap:Revenues |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | $155.6m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2024-01-01 to 2024-12-31 | $167.6m | us-gaap:GrossProfit |
| Research and development | 12 months2024-01-01 to 2024-12-31 | $71.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2024-01-01 to 2024-12-31 | −$15.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2024-01-01 to 2024-12-31 | −$3.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-01-01 to 2024-12-31 | $1.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 319,146,281 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | $31.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | $8.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-12-31 | $177.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $363.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $473.9m | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $126.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-12-31 | $156.1m | us-gaap:Liabilities |
| Long-term debt | At period end2024-12-31 | $27.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-12-31 | $696.0k | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2024-12-31 | $1.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-12-31 | $318.1m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-12-31 | 307,351,196 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001410578-25-000871. Last ingested by Listed: Nov 12, 2026, 17:22 ET. Listed shows no prices and gives no investment advice.